000 | 05016cam a2200553 i 4500 | ||
---|---|---|---|
999 |
_c200452150 _d70362 |
||
001 | 200452150 | ||
003 | TR-AnTOB | ||
005 | 20241227162003.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 220603t20222022njua ob 001 0 eng d | ||
020 |
_a9781119785033 _qelectronic book |
||
020 |
_a1119785030 _qelectronic book |
||
020 |
_a9781119785019 _qelectronic book |
||
020 |
_a1119785014 _qelectronic book |
||
020 |
_a9781119785026 _qelectronic book |
||
020 |
_a1119785022 _qelectronic book |
||
020 |
_z9781119785002 _qpaperback |
||
035 | _a(OCoLC)1327844146 | ||
040 |
_aDLC _beng _erda _cDLC _dYDX _dDG1 |
||
041 | 0 | _aeng | |
042 | _apcc | ||
060 | 0 | 0 |
_aWK 825 _bD536 2022 |
096 |
_aWK 825 _bD536 2022EBK |
||
245 | 0 | 0 |
_aDiabetes drug notes / _cedited by Miles Fisher, Gerard A. McKay, Andrea Llano |
264 | 1 |
_aHoboken, NJ : _bWiley-Blackwell, _c2022. |
|
264 | 4 | _c©2022 | |
300 |
_a1 online resource (xxiv, 368 pages) : _billustrations (some color) |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
504 | _aBIBINDX | ||
505 | 0 | _aClinical pharmacology of antidiabetic drugs / Andrea Llano, Gerry McKay, and Ken Paterson -- Metformin / Joseph G. Timmons and James G. Boyle -- Sulfonylureas and meglitinides -- Joseph G. Timmons and James G. Boyle -- DPP-4 inhibitors / Sharon Mackin and Gemma Currie -- SGLT2 inhibitors / Miles Fisher, Andrea Llano, and Gerry McKay -- GLP-1 receptor agonists / Catherine Russell and John R. Petrie -- Animal and human insulin / Ken Paterson -- Short-ccting insulin analogues / Kate Hughes and Gerry McKay -- Long-acting Insulin Analogues / Robert Lindsay -- Devices / David Carty -- Acarbose and alpha glucosidase inhibitors / Miles Fisher -- Glitazones and glitazars / Miles Fisher -- Other antidiabetic drugs / Maroria Oroko, Andrea Llano, and Miles Fisher -- Future antidiabetic drugs / Emma Johns and Miles Fisher -- Guidelines / Miles Fisher and Russell Drummond -- Prescribing antidiabetic drugs / Andrea Llano, Gerry McKay, Frances McManus, Catriona McClements, Joyce McKenzie, and Deborah Morrison | |
520 |
_a"At Glasgow Royal Infirmary historically diabetes and clinical pharmacology were linked with specialists in each discipline contributing to one of the medical units in the provision of general medical care to the inhabitants of the east of Glasgow whilst delivering specialist expertise. A few miles north of the Royal Infirmary, Stobhill Hospital in its prime had physicians delivering care who were also delivering academic excellence in the Department of Materia Medica at the University of Glasgow. In 2011 the two hospitals in the northeast of Glasgow merged to provide in patient care on one site and in doing so brought together the prospect of having a combined Department of Diabetes, Endocrinology and Clinical Pharmacology. In addition to having a long-standing reputation for recruiting patients to commercial studies, the Royal Infirmary has strong links with the University of Glasgow, with senior academics continuing to provide both general and specialist patient care, and the University of Strathclyde Institute of Pharmacy and Biomedical Sciences, specifically around training independent pharmacy prescribers. Education and training have been hallmarks of the department and in 2008 a series of Drug Notes was established for Practical Diabetes, covering drugs used in those with diabetes but not necessarily ones for lowering blood glucose, encouraging trainees to be first authors. The series is still going, suggesting that an understanding of drugs is an essential part of being a healthcare provider with an interest in diabetes. Antidiabetic drugs were covered in two separate series for the British Journal of Cardiology, again with trainees aspiring to be specialists in diabetes and endocrinology being first authors and to consider clinical pharmacology as a key knowledge skill"-- _cProvided by publisher |
||
650 | 2 |
_aDiabetes Mellitus _xChemotherapy. _9120560 |
|
650 | 0 |
_aDrugs _987453 |
|
650 | 1 | 2 |
_aHypoglycemic Agents _xpharmacology. _0https://id.nlm.nih.gov/mesh/D007004Q000494 |
650 | 2 | 2 |
_aGlycoside Hydrolase Inhibitors _xpharmacology. _0https://id.nlm.nih.gov/mesh/D065089Q000494 |
650 | 2 | 2 |
_aInsulins _xpharmacology. _0https://id.nlm.nih.gov/mesh/D061385Q000494 |
650 | 2 | 2 |
_aDiabetes Mellitus _xdrug therapy. _0https://id.nlm.nih.gov/mesh/D003920Q000188 |
655 | 0 |
_aElectronic books _92032 |
|
700 | 1 |
_aFisher, Miles, _0http://id.loc.gov/authorities/names/nb2003011090 _eeditor |
|
700 | 1 |
_aMcKay, Gerard A., _0http://id.loc.gov/authorities/names/n2010181936 _eeditor |
|
700 | 1 |
_aLlano, Andrea, _0http://id.loc.gov/authorities/names/n2022182238 _eeditor |
|
856 | 4 | 0 |
_3Wiley Online Library _zConnect to resource _uhttps://onlinelibrary.wiley.com/doi/book/10.1002/9781119785033 |
942 |
_2NLM _cEBK |